Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Brian E, Ward"'
Autor:
William E. Pierceall, Michele Wolfe, Jessica Suschak, Hua Chang, Yan Chen, Kam M. Sprott, Jeffery L. Kutok, Stella Quan, David T. Weaver, Brian E. Ward
Publikováno v:
Analytical Cellular Pathology, Vol 34, Iss 3, Pp 159-168 (2011)
Digital quantitative immunohistochemical analysis of protein biomarker expression offers a broad dynamic range against which clinical outcomes may be measured. Semi-quantitative expression data represented as an H-score is produced by computer genera
Externí odkaz:
https://doaj.org/article/c3d2f9acca124062a912c1cd75184915
Physiologic Long Head Biceps Tendon Excursion Throughout Shoulder Range of Motion: A Cadaveric Study
Publikováno v:
Orthopaedic Journal of Sports Medicine
Background: Restoration of the long head of the biceps tendon (LHBT) length-tension relationship is critical in preserving muscle strength and efficiency when performing biceps tenodesis. While static anatomic landmarks such as the inferior border of
Autor:
Joshua S. Dines, Brian E Ward
Publikováno v:
American journal of orthopedics (Belle Mead, N.J.). 47(2)
Optimal outcomes following total shoulder arthroplasty TSA and reverse shoulder arthroplasty RSA are dependent on proper implant position. Multiple cadaver studies have demonstrated improved accuracy of implant positioning with use of patient-specifi
Publikováno v:
Journal of Histotechnology. 33:172-178
Two important criteria used to select an antibody diluent for robust immunohistochemistry are: (1) optimal signal/noise ratio, and (2) long-term stability when diluted. For immunohistochemistry with Fanconi anemia, complementation group D2 (FANCD2) i
Autor:
Lynn Anne Burbidge, Michael J. Hall, Walter W. Noll, Richard J. Wenstrup, Thomas Scholl, Julia Reid, Dmitry Pruss, Cynthia Frye, Amie M. Deffenbaugh, Brian E. Ward
Publikováno v:
Cancer. 115:2222-2233
Background In women at increased risk for breast and ovarian cancer, the identification of a BRCA1/2 mutation has important implications for screening and prevention counseling. Uncertainty regarding the role of BRCA1/2 testing in high-risk women fro
Autor:
Brian E Ward, Madhuri Hegde, Wayne W. Grody, C. Sue Richards, Sherri J. Bale, Elaine Lyon, Daniel B. Bellissimo, Soma Das
Publikováno v:
Genetics in Medicine. 10:294-300
ACMG previously developed recommendations for standards for interpretation of sequence variations. We now present the updated revised recommendations. Here, we describe six interpretative categories of sequence variations: (1) sequence variation is p
Autor:
Elena M. Stoffel, Lynn Anne Burbidge, David H. Stockwell, Brant C. Hendrickson, John Tazelaar, Ewout W. Steyerberg, Amie M. Deffenbaugh, Thomas Scholl, J. Balmaña, Sapna Syngal, Julia Reid, Brian E. Ward
Publikováno v:
JAMA-Journal of the American Medical Association, 296(12), 1469-1478. American Medical Association
textabstractContext: Lynch syndrome is caused primarily by mutations in the mismatch repair genes MLH1 and MSH2. Objectives: To analyze MLH1/MSH2 mutation prevalence in a large cohort of patients undergoing genetic testing and to develop a clinical m
Autor:
Brian E. Ward, Kristilyn Eliason, Brant C. Hendrickson, Michael J. Norton, Dmitri Pruss, Thomas Scholl, Amie M. Deffenbaugh, Thaddeus Judkins, Benoît Leclair
Publikováno v:
Cancer Research. 65:10096-10103
This work describes an approach to characterize the clinical significance of genetic variants detected during the genetic testing of BRCA1 in patients from hereditary breast/ovarian cancer families. Results from transgenic mice and extensive clinical
Autor:
Bruce Budowle, John H. Ryan, Jeffrey K. Barrus, Cynthia M. Shannon, Brian E. Ward, Victor W. Thompson
Publikováno v:
Journal of Forensic Sciences. 49:1-8
A powerful method for validating a scientific result is to confirm specific results utilizing independent methodologies and processing pathways. Thus, we have designed, developed and validated an automated allele concordance analysis system (CompareC
Autor:
Alun Thomas, Malcom Beinfield, Bruce C. Turner, Elizabeth Harrold, Mark H. Skolnick, Peter M. Glazer, Brian E. Ward, Andrew A. Gumbs, Ellen T. Matloff, Tanya Smith, Bruce G. Haffty
Publikováno v:
Journal of Clinical Oncology. 17:3017-3024
PURPOSE: Breast cancer patients treated conservatively with lumpectomy and radiation therapy (LRT) have an estimated lifetime risk of local relapse (ipsilateral breast tumor recurrence [IBTR]) of 10% to 15%. For breast cancer patients carrying BRCA1